The CSA-NGAL score, in addition to the functional score of AKI, can be used in prospective studies of patients having cardiac operations to identify subclinical AKI early and to take relevant interventions to prevent further injury or the development of functional AKI (de Geus et al., 2016). The gene discussed is LCN2; the disease is acute kidney injury.